Li, X., Lu, J., Zhang, L., Luo, Y., Zhao, Z., & Li, M. (2020). Clinical Implications of Monitoring ESR1 Mutations by Circulating Tumor DNA in Estrogen Receptor Positive Metastatic Breast Cancer. Translational Oncology, 13(2), 321. https://doi.org/10.1016/j.tranon.2019.11.007
Chicago-referens (17:e uppl.)Li, Xuelu, Jiawei Lu, Lanxin Zhang, Yaoting Luo, Zuowei Zhao, och Man Li. "Clinical Implications of Monitoring ESR1 Mutations by Circulating Tumor DNA in Estrogen Receptor Positive Metastatic Breast Cancer." Translational Oncology 13, no. 2 (2020): 321. https://doi.org/10.1016/j.tranon.2019.11.007.
MLA-referens (9:e uppl.)Li, Xuelu, et al. "Clinical Implications of Monitoring ESR1 Mutations by Circulating Tumor DNA in Estrogen Receptor Positive Metastatic Breast Cancer." Translational Oncology, vol. 13, no. 2, 2020, p. 321, https://doi.org/10.1016/j.tranon.2019.11.007.
